$2.60
+0.11 (+4.42%)
Open$2.56
Previous Close$2.49
Day High$2.65
Day Low$2.48
52W High$9.99
52W Low$2.40
Volume—
Avg Volume900.3K
Market Cap21.79M
P/E Ratio—
EPS$0.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,601.2% upside
Current
$2.60
$2.60
Target
$44.23
$44.23
$32.29
$44.23 avg
$55.91
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.90M | 15.57M | 15.33M |
| Net Income | 2.99M | 2.88M | 3.11M |
| Profit Margin | 17.7% | 18.5% | 20.3% |
| EBITDA | 3.97M | 4.34M | 3.61M |
| Free Cash Flow | 3.54M | 3.27M | 3.55M |
| Rev Growth | +19.1% | +9.8% | -6.9% |
| Debt/Equity | 0.36 | 0.34 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |